Zhang Wen, Tao Xiao-Juan, Cheng Jun
Department of Nephrology, Integrative Medicine Hospital Affiliated to Zhejiang University of Traditional Chineses Medicine, Hangzhou.
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2009 Aug;29(8):703-6.
To investigate the effect of Shenmai Injection (SMI) on patients undergoing maintenance hemodialysis (MHD) suffered from malnutrition-inflammation complex syndrome (MICS).
Forty patients undergoing MHD were randomly allocated into two groups, the SMI group and the control group, 20 in each group. They were treated for three months. Blood levels of albumin (Alb), high-sensitivity C-reactive protein (hs-CRP), interleukin 6 (IL-6) and interleukin 1beta (IL-1beta) as well as stomatologic parameters were measured before and after treatment. Meantime, the modified subjective global analysis of nutrition (SGAN) was used to assess patients' nutritional status, and the quantitative scoring system was adopted to get the malnutrition score (MS).
In the SMI group after treatment, levels of MS, hs-CRP, IL-6 and IL-1beta were lowered, levels of Alb, body weight, and SSF were increased significantly (P <0.05 or P <0.01); as compared with those in the control group, MS, hs-CRP and IL-6 were lower, while SSF and Alb were higher (P<0.05 or P< 0.01). Levels of IL-6 and IL-1beta, either in the SMI group or in the control group, were all higher than normal range (P<0.05). Correlation analysis showed significant correlation presented between MS value with levels of Alb (P<0.01) and IL-6 (P <0.05), also between IL-6 and Alb (P<0.05).
SMI can reduce the blood levels of hs-CRP, IL-6 and IL-1beta in patients undergoing MHD, improve their nutritional indices, suggesting that it could alleviate the MICS in these patients.
探讨参麦注射液(SMI)对维持性血液透析(MHD)患者营养不良 - 炎症复合综合征(MICS)的影响。
将40例MHD患者随机分为两组,即SMI组和对照组,每组20例。治疗3个月。分别于治疗前后检测血白蛋白(Alb)、高敏C反应蛋白(hs - CRP)、白细胞介素6(IL - 6)、白细胞介素1β(IL - 1β)水平及口腔学参数。同时,采用改良主观全面营养评定法(SGAN)评估患者营养状况,并采用定量评分系统得出营养不良评分(MS)。
SMI组治疗后,MS、hs - CRP、IL - 6及IL - 1β水平降低,Alb、体重及血清前白蛋白(SSF)水平显著升高(P <0.05或P <0.01);与对照组相比,MS、hs - CRP及IL - 6较低,而SSF及Alb较高(P<0.05或P<0.01)。SMI组和对照组的IL - 6及IL - 1β水平均高于正常范围(P<0.05)。相关性分析显示,MS值与Alb水平(P<0.01)及IL - 6水平(P <0.05)之间存在显著相关性,IL - 6与Alb之间也存在显著相关性(P<0.05)。
SMI可降低MHD患者血hs - CRP、IL - 6及IL - 1β水平,改善其营养指标,提示其可缓解这些患者的MICS。